High-Throughput Screening Market Segmentation:
Products & Services Segment Analysis
The consumables segment is estimated to gain the largest market share over the projected time frame, attributed to the increasing demand for new and advanced drugs. The adoption of HTS for developing new drugs is anticipated to create numerous opportunities for the growth of the segment. For instance, microplates, pipette tips, and assay plates are consumables that are essential to the HTS workflow. In addition, improvements in HTS technology that enable more intricate and varied screening trials rises the demand for consumables. Furthermore, the need for specialized consumables will probably increase as HTS technologies develop further. By 2026, over 200 new medications are anticipated to be released across the globe.
End-user Segment Analysis
The pharmaceutical & biotechnology firms segment is expected to garner a significant share, attributed to the increasing creation of new compounds to cure many chronic diseases. High-throughput screening (HTS) is widely used in the pharmaceutical and biotechnology industries to find new drugs. Further, the drug development process has been transformed by HTS technology, which allows scientists to quickly screen millions of molecules. As a result, several novel medications have been created to treat a variety of illnesses and ailments, such as cancer, cardiovascular, and infectious diseases. This, as a result, is anticipated to create numerous opportunities for the growth of the segment.
Our in-depth analysis of the global market includes the following segments:
|
By Products & Services |
|
|
By Technology |
|
|
By Application |
|
|
By End User |
|
